Experience with poliovaccines in the control of poliomyelitis in India

T J John1

  • 1Christian Medical College and Hospital, Vellore, India.

Public Health Reviews
|January 1, 1993
PubMed

OPV was introduced in the National Immunisation Programme (NIP) in 1979. The reported number of cases of poliomyelitis was about 20,000 in 1979, 38,000 in 1981; it gradually declined to the pre-immunisation level of 20,000 in 1986, but increased to 28,000 in 1987. In 1989, 10 years after NIP, the reported number of cases fell below the pre-immunisation level, and has further declined to 5669 in 1991. The 3-dose OPV coverage during infancy was estimated to be about 80% in 1991. If reporting efficiency is 10%, then about 60,000 cases would have occurred in 1991, for an incidence of disease of about 7/100,000 in the total population of 840 million. Three questions arise: (1) Why did it take over 10 years of NIP to reduce the disease burden? (2) Why is the disease occurring at a high incidence level in spite of 80% immunisation coverage? (3) Will we be able to eliminate poliomyelitis and eradicate polioviruses by the year 2000 by sustaining the high immunisation coverage using 3 doses of OPV? In most countries, the incidence of disease has declined immediately after instituting NIP including OPV. The vaccine efficacy (VE) of 3 doses of OPV in India is 70-93%. Hence the lack of decline of incidence during 10 years of NIP was most probably because sufficient proportions of infants were not being immunised. The incidence remains high because the VE and herd effect of 3 doses of OPV are insufficient. Vaccine failure cases will account for 2-9 cases per 100,000 per year since pre-immunisation incidence was 30 and VE is 70-93%.(ABSTRACT TRUNCATED AT 250 WORDS)

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
Immunological Memory01:23

Immunological Memory

Immunological memory, a pivotal pillar of the adaptive immune system, is responsible for the body's ability to remember and respond more swiftly and effectively to previously encountered pathogens. This remarkable feature is what makes vaccines so effective in preventing diseases.
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature is...
Vaccines01:21

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
Smallpox01:24

Smallpox

Smallpox is a severe contagious disease caused by the Variola major virus, a double-stranded DNA member of the Poxviridae family.Variola major transmission occurs primarily via inhalation of virus-laden droplets or direct contact with infectious scabs. The incubation period averages approximately seven days, although it may range from 7 to 17 days depending on the inoculum and host factors.Clinically, the prodromal phase is marked by an abrupt onset of high fever, malaise, headache, and myalgia.
Chickenpox01:20

Chickenpox

Chickenpox is an acute, highly contagious disease caused by the varicella-zoster virus (VZV), a double-stranded DNA virus belonging to the Herpesviridae family. Its transmission occurs primarily through the inhalation of respiratory droplets or direct contact with vesicular fluid from skin lesions. The incubation period typically ranges from 10 to 21 days, during which the virus replicates and disseminates through sequential phases within the host. Although generally self-limiting in children,...
Poliomyelitis01:17

Poliomyelitis

Poliomyelitis is caused by poliovirus, a small, non-enveloped, positive-sense RNA virus of the Picornaviridae family and Enterovirus genus. Transmission occurs primarily via the fecal-oral route, often through ingestion of contaminated water or food. The virus initially replicates in the oropharynx and intestinal mucosa, particularly in lymphoid tissues such as the tonsils, Peyer’s patches, and regional lymph nodes. Primary viremia follows, allowing dissemination throughout the body.In most...